COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 4 of 458 for:    shaare zedek

The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01266629
Recruitment Status : Unknown
Verified October 2010 by Shaare Zedek Medical Center.
Recruitment status was:  Recruiting
First Posted : December 24, 2010
Last Update Posted : January 11, 2011
Information provided by:
Shaare Zedek Medical Center

Brief Summary:
Capsule endoscopy (CE) is considered as a gold standard examination for small bowel Crohn's disease. However, it is time-consuming, expensive and results are largely influenced by the operator's skills. We, therefore, want to assess the predictive value of fecal calprotectin and lactoferrin in patients undergoing CE.

Condition or disease
Crohn's Disease

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Clinical Utility of Fecal Calprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy: A Prospective Study
Study Start Date : December 2010
Estimated Primary Completion Date : June 2011
Estimated Study Completion Date : September 2011

Resource links provided by the National Library of Medicine

capsule patients
All patients that will undergo endoscopic capsule

Primary Outcome Measures :
  1. correlations between capsule and fecal markers [ Time Frame: end of the study ]
    To assess the correlations between positive fecal markers and abnormal findings in endoscopic capsule

Secondary Outcome Measures :
  1. correlations between serum markers and capsule [ Time Frame: end of the study ]
    correlations between CRP, ESR , PLT and abnormal findings in capsule

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consecutive patients referred for capsule on an outpatient basis will include in the study. Indications for EC will be suspicion of crohn's disease, unexplained anemia, and bleeding, and abnormal findings in commuted tomography. All patients underwent non diagnostic colonoscopy and gastroscopy prior to EC referral.

Inclusion Criteria:All consecutive patients referred for endoscopic capsule -

Exclusion Criteria:Intake of nonsteroidal agents and/or antibiotics during the three months preceding the study, concomitant serious illness, pregnancy, alcohol abuse, and evidence of a respiratory tract infection.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01266629

Layout table for location contacts
Contact: Ariella Shitrit, MD 972-525751515

Layout table for location information
Shaare Zedek Recruiting
Jerusalem, Israel
Contact: Ariella Shitrit, MD    972-26555111   
Sponsors and Collaborators
Shaare Zedek Medical Center
Layout table for investigator information
Principal Investigator: Ariella Shitrit, MD Shaare Zedek Medical Center
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ariella Shitrit Shaare Zedek Medical Center, Shaare Zedek Medical Center Identifier: NCT01266629    
Other Study ID Numbers: 2010-147
First Posted: December 24, 2010    Key Record Dates
Last Update Posted: January 11, 2011
Last Verified: October 2010
Keywords provided by Shaare Zedek Medical Center:
small bowel
Additional relevant MeSH terms:
Layout table for MeSH terms
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases